Found: 31
Select item for more details and to access through your institution.
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 551, doi. 10.2147/CEOR.S203482
- By:
- Publication type:
- Article
Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 87, doi. 10.2147/CEOR.S187409
- By:
- Publication type:
- Article
BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5399, doi. 10.3390/cancers14215399
- By:
- Publication type:
- Article
Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0165276
- By:
- Publication type:
- Article
Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996-2000.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 1, p. 113, doi. 10.1592/phco.23.1.113.31910
- By:
- Publication type:
- Article
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. e737, doi. 10.1093/oncolo/oyad046
- By:
- Publication type:
- Article
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 780, doi. 10.1093/oncolo/oyad045
- By:
- Publication type:
- Article
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity.
- Published in:
- Health Economics, 2006, v. 15, n. 10, p. 1091, doi. 10.1002/hec.1099
- By:
- Publication type:
- Article
Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 8, p. 3076, doi. 10.1007/s12325-024-02888-9
- By:
- Publication type:
- Article
Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4480, doi. 10.1007/s12325-023-02572-4
- By:
- Publication type:
- Article
Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 331, doi. 10.1007/s12325-022-02302-2
- By:
- Publication type:
- Article
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2–negative advanced breast cancer from the United States, Europe, and Israel
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10325-9
- By:
- Publication type:
- Article
The value of new drugs for advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3457, doi. 10.1002/cncr.33662
- By:
- Publication type:
- Article
Clinical characteristics, treatment patterns, and outcomes in adult patients with germline BRCA1/2-mutated, HER2-negative advanced breast cancer: a retrospective medical record review in the United States.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1341665
- By:
- Publication type:
- Article
Pregnancy after Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0117525
- By:
- Publication type:
- Article
Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0072723
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0067260
- By:
- Publication type:
- Article
Survey of hospital policies regarding low-molecular-weight heparins.
- Published in:
- American Journal of Health-System Pharmacy, 2002, v. 59, n. 6, p. 1, doi. 10.1093/ajhp/59.6.534
- By:
- Publication type:
- Article
Budgetary Impact of Thiazolidinedione (TZD) Add-On Therapy Relative to Insulin (INS) Add-On Therapy in Individuals Treated with Sulfonylureas (SU): A Third Party Payer's Perspective.
- Published in:
- Diabetes, 2007, v. 56, p. A653
- By:
- Publication type:
- Article
Economic Analysis of Add--on Therapy with Thiazolidinedione (TZD) versus Insulin (INS) to Metformin (MET) Monotherapy.
- Published in:
- Diabetes, 2007, v. 56, p. A653
- By:
- Publication type:
- Article
Triple Therapy with Rosiglitazone (RSG) or Insulin (INS) and Associated Medical Resource Use (MRU) and Costs in Type 2 Diabetes (T2D).
- Published in:
- Diabetes, 2007, v. 56, p. A650
- By:
- Publication type:
- Article
Comparison of Resources Utilization (RU) and Costs in Drug-Naive Type 2 Diabetes (T2D) Patients (Pts) Treated with Rosiglitazone (RSG)/ Metformin (MET) as Fixed-Dose Combination (FDC) vs. Sulfonylurea (SU) plus Metformin (MET) as Combination Therapy (CT).
- Published in:
- Diabetes, 2007, v. 56, p. A558
- By:
- Publication type:
- Article
Add-On Therapy with Rosiglitazone (RSG)/Metformin (MET) as a Fixed-Dose Combination (FDC) vs RSG plus MET or RSG plus Sulfonylurea (SU) as Separate Pills (SP): Retrospective Study of Outcomes and Costs.
- Published in:
- Diabetes, 2007, v. 56, p. A558
- By:
- Publication type:
- Article
Impact of Multiple Medication Use for Treatment of Diabetes and Lipid Disorders on Therapy Compliance, LDL, and HbA1c.
- Published in:
- Diabetes, 2007, v. 56, p. A553
- By:
- Publication type:
- Article
Association of Medical Costs and Pre-Diabetic Dysglycemia.
- Published in:
- Diabetes, 2007, v. 56, p. A310
- By:
- Publication type:
- Article
Comparison of Resources Utilization (RU) and Costs in Drug Naïve Type 2 Diabetic (T2D) Patients Treated with Rosiglitazone (RSG) vs. Sulfonylurea (SU) Monotherapy.
- Published in:
- Diabetes, 2007, v. 56, p. A309
- By:
- Publication type:
- Article
Validation of a Simple Screening Tool for Detecting Undiagnosed Diabetes and Prediabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A255
- By:
- Publication type:
- Article
A Simple Screening Tool for Detecting Undiagnosed Diabetes and Prediabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A253
- By:
- Publication type:
- Article
Diabetes Risk Calculator.
- Published in:
- Diabetes Care, 2008, v. 31, n. 5, p. 1040, doi. 10.2337/dc07-1150
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 3, p. 671, doi. 10.1007/s00432-020-03414-4
- By:
- Publication type:
- Article